Hinke Siebinga (H Siebinga)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Radical Prostatectomy

Ejection Fraction

Neuroendocrine Tumors

Top Venues

EJNMMI research

European journal of nuclear medicine and molecular imaging

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Hinke Siebinga, Berlinda J de Wit-van der Veen, Daphne M V de Vries-Huizing, Wouter V Vogel, Jeroen J M A Hendrikx, Alwin D R Huitema
Quantification of biochemical PSA dynamics after radioligand therapy with [ 177 Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model. EJNMMI physics 11 (1) (2024)
Hinke Siebinga, Berlinda J de Wit-van der Veen, Daphne M V de Vries-Huizing, Wouter V Vogel, Jeroen J M A Hendrikx, Alwin D R Huitema
Quantification of biochemical PSA dynamics after radioligand therapy with [ 177 Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model. EJNMMI physics 11 (1) (2024)
Hinke Siebinga, Berlinda J de Wit-van der Veen, Daphne M V de Vries-Huizing, Wouter V Vogel, Jeroen J M A Hendrikx, Alwin D R Huitema
Quantification of biochemical PSA dynamics after radioligand therapy with [ 177 Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model. EJNMMI physics 11 (1) (2024)
Hinke Siebinga, Berlinda J de Wit-van der Veen, Jos H Beijnen, Thomas P C Dorlo, Alwin D R Huitema, Jeroen J M A Hendrikx
A physiologically based pharmacokinetic model for [ 68 Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients. EJNMMI research 13 (1) (2023)
Hinke Siebinga, Berlinda J de Wit-van der Veen, Jos H Beijnen, Thomas P C Dorlo, Alwin D R Huitema, Jeroen J M A Hendrikx
A physiologically based pharmacokinetic model for [ 68 Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients. EJNMMI research 13 (1) (2023)
Chayenne H A M Veerman, Hinke Siebinga, Daphne M V de Vries-Huizing, Margot E T Tesselaar, Jeroen J M A Hendrikx, Marcel P M Stokkel, Else A Aalbersberg
The effect of long-acting somatostatin analogues on the uptake of [ 177 Lu]Lu-HA-DOTATATE. European journal of nuclear medicine and molecular imaging 50 (5) (2023)
Hinke Siebinga, Berlinda J de Wit-van der Veen, Jos H Beijnen, Thomas P C Dorlo, Alwin D R Huitema, Jeroen J M A Hendrikx
A physiologically based pharmacokinetic model for [ 68 Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients. EJNMMI research 13 (1) (2023)
Chayenne H A M Veerman, Hinke Siebinga, Daphne M V de Vries-Huizing, Margot E T Tesselaar, Jeroen J M A Hendrikx, Marcel P M Stokkel, Else A Aalbersberg
The effect of long-acting somatostatin analogues on the uptake of [ 177 Lu]Lu-HA-DOTATATE. European journal of nuclear medicine and molecular imaging 50 (5) (2023)
Hinke Siebinga, Jeroen J M A Hendrikx, Alwin D R Huitema, Berlinda J de Wit-van der Veen
Predicting the effect of different folate doses on [ 68 Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling. EJNMMI research 13 (1) (2023)
Hinke Siebinga, Berlinda J de Wit-van der Veen, Jos H Beijnen, Thomas P C Dorlo, Alwin D R Huitema, Jeroen J M A Hendrikx
A physiologically based pharmacokinetic model for [ 68 Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients. EJNMMI research 13 (1) (2023)
Hinke Siebinga, J J M A Hendrikx, D M V de Vries-Huizing, A D R Huitema, B J de Wit-van der Veen
The cycle effect quantified: reduced tumour uptake in subsequent cycles of [ 177 Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy. European journal of nuclear medicine and molecular imaging (2023)
Chayenne H A M Veerman, Hinke Siebinga, Daphne M V de Vries-Huizing, Margot E T Tesselaar, Jeroen J M A Hendrikx, Marcel P M Stokkel, Else A Aalbersberg
The effect of long-acting somatostatin analogues on the uptake of [ 177 Lu]Lu-HA-DOTATATE. European journal of nuclear medicine and molecular imaging (2023)
Hinke Siebinga, Bastiaan M Privé, Steffie M B Peters, James Nagarajah, Thomas P C Dorlo, Alwin D R Huitema, Berlinda Jantina de Wit-van der Veen, Jeroen J M A Hendrikx
Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of 177 Lu-PSMA-617 in prostate cancer patients. CPT: pharmacometrics & systems pharmacology (2023)
Hinke Siebinga, Berlinda J de Wit-van der Veen, Jos H Beijnen, Marcel P M Stokkel, Thomas P C Dorlo, Alwin D R Huitema, Jeroen J M A Hendrikx
Predicting [ 177 Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [ 68 Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling. EJNMMI physics 10 (1) (2023)
Hinke Siebinga, Chayenne H A M Veerman, Berlinda Jantina de Wit-van der Veen, Marcel P M Stokkel, Jeroen J M A Hendrikx, Else A Aalbersberg
Somatostatin receptor saturation after administration of high peptide amounts of [ 177 Lu]Lu-HA-DOTATATE: when enough is enough. EJNMMI research 12 (1) (2022)
Hinke Siebinga, Judith Olde Heuvel, Erik-Jan Rijkhorst, Jeroen J M A Hendrikx, Berlinda J de Wit-van der Veen
The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68 Ga-PSMA-11 PET/CT in Primary Prostate Cancer Patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Hinke Siebinga, Chayenne H A M Veerman, Berlinda Jantina de Wit-van der Veen, Marcel P M Stokkel, Jeroen J M A Hendrikx, Else A Aalbersberg
Somatostatin receptor saturation after administration of high peptide amounts of [ 177 Lu]Lu-HA-DOTATATE: when enough is enough. EJNMMI research 12 (1) (2022)
Hinke Siebinga, Chayenne H A M Veerman, Berlinda Jantina de Wit-van der Veen, Marcel P M Stokkel, Jeroen J M A Hendrikx, Else A Aalbersberg
Somatostatin receptor saturation after administration of high peptide amounts of [ 177 Lu]Lu-HA-DOTATATE: when enough is enough. EJNMMI research 12 (1) (2022)
Hinke Siebinga, B J de Wit-van der Veen, J H Beijnen, M P M Stokkel, T P C Dorlo, A D R Huitema, J J M A Hendrikx
A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors. EJNMMI research 11 (1) (2021)